Johnson   Johnson Profit Up on Drug Sales  NEW YORK (Reuters) - Diversified health-care company  Johnson   Johnson &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=JNJ.N target=/stocks/quickinfo/fullquote"&gt;JNJ.N&lt;/A&gt; on Tuesday said its quarterly profit  rose on higher sales of prescription drugs and medical devices.